ImClone Investigational Site

Paris 75674

0 studies enrolling now · 5 studies all time

What they study most

Adipocytic Sarcoma, Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET), Gastric Cancer, Hepatocellular Carcinoma, Leiomyosarcoma, Non Small Cell Lung Cancer, Rhabdomyosarcoma, Synovial Sarcoma

Studies at this site

• First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin — Completed
• First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin — Completed
• A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma — Completed
• A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma — Completed
• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib — Completed